DK1488790T3 - Fast præparat indeholdende en enkeltkrystalform A af etthiazolcarboxylsyrederivat - Google Patents
Fast præparat indeholdende en enkeltkrystalform A af etthiazolcarboxylsyrederivatInfo
- Publication number
- DK1488790T3 DK1488790T3 DK03715586.8T DK03715586T DK1488790T3 DK 1488790 T3 DK1488790 T3 DK 1488790T3 DK 03715586 T DK03715586 T DK 03715586T DK 1488790 T3 DK1488790 T3 DK 1488790T3
- Authority
- DK
- Denmark
- Prior art keywords
- ethiazole
- carboxylic acid
- single crystal
- composition containing
- acid derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002090889 | 2002-03-28 | ||
PCT/JP2003/003962 WO2003082279A1 (fr) | 2002-03-28 | 2003-03-28 | Preparation solide contenant une forme monocristalline |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1488790T3 true DK1488790T3 (da) | 2014-10-13 |
Family
ID=28671666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03715586.8T DK1488790T3 (da) | 2002-03-28 | 2003-03-28 | Fast præparat indeholdende en enkeltkrystalform A af etthiazolcarboxylsyrederivat |
Country Status (13)
Country | Link |
---|---|
US (1) | US7361676B2 (da) |
EP (1) | EP1488790B1 (da) |
JP (1) | JP4084309B2 (da) |
KR (1) | KR100981905B1 (da) |
CN (2) | CN1642546A (da) |
AU (1) | AU2003220909B2 (da) |
CA (1) | CA2474674C (da) |
CY (1) | CY1115490T1 (da) |
DK (1) | DK1488790T3 (da) |
ES (1) | ES2505690T3 (da) |
PT (1) | PT1488790E (da) |
SI (1) | SI1488790T1 (da) |
WO (1) | WO2003082279A1 (da) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1956014T (pt) | 1998-06-19 | 2019-04-24 | Teijin Pharma Ltd | Polimorfos de ácido 2-(3-ciano-4-isobutiloxifenil)-4-metil- 5-tiazolecarboxílico e método para a sua produção |
CN100430055C (zh) * | 2005-11-11 | 2008-11-05 | 天津泰普药品科技发展有限公司 | 2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸和聚乙烯吡咯烷酮玻璃态固溶体及其制备方法 |
CN101139325B (zh) * | 2006-09-07 | 2010-05-12 | 上海医药工业研究院 | 2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸晶型及其制备方法 |
CN101812035B (zh) * | 2006-09-07 | 2012-03-21 | 上海医药工业研究院 | 2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸晶型及其制备方法 |
BRPI0718611A2 (pt) * | 2006-11-13 | 2014-02-25 | Takeda Pharmaceuticals North America Inc | Métodos para preservar a função renal utilizando inibidores da xantina oxidoredutase. |
CN102093308B (zh) * | 2006-12-07 | 2012-08-29 | 重庆医药工业研究院有限责任公司 | 非布司他的晶型及其制备方法 |
CN1970547B (zh) * | 2006-12-07 | 2011-04-06 | 重庆医药工业研究院有限责任公司 | 非布司他的晶型及其制备方法 |
CN101412700B (zh) * | 2007-10-19 | 2011-06-08 | 上海医药工业研究院 | 非布司他的晶型及其制备方法 |
CN101386605B (zh) * | 2008-10-23 | 2010-09-08 | 中国科学院上海药物研究所 | 非布司他新型晶体及其制备方法 |
CN101474175B (zh) * | 2009-01-20 | 2014-07-02 | 重庆医药工业研究院有限责任公司 | 一种高生物利用度非布司他口服固体制剂及其制备方法 |
CN101780073B (zh) * | 2009-01-21 | 2013-07-03 | 重庆圣华曦药业股份有限公司 | 非布司他分散片药物及其制备方法 |
US20100311756A1 (en) * | 2009-01-22 | 2010-12-09 | Takeda Pharmaceuticals North America, Inc. | Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof |
CN102803240A (zh) | 2009-06-10 | 2012-11-28 | 特瓦制药工业有限公司 | 非布索坦的晶形 |
CN102070558B (zh) * | 2009-11-23 | 2012-08-22 | 欣凯医药化工中间体(上海)有限公司 | 非布索坦的新晶型及其制备方法 |
CN101824005B (zh) * | 2010-04-27 | 2012-06-27 | 上海凯米侬医药科技有限公司 | 一种非布索坦的晶型q及其制备方法 |
MX339452B (es) * | 2010-06-16 | 2016-05-27 | Teijin Pharma Ltd | Tableta con nucleo recubierto de liberacion controlada. |
DK2399911T3 (da) | 2010-06-25 | 2015-09-07 | Sandoz Ag | Polymorfer af Febuxostat. |
BR112013000300A2 (pt) * | 2010-07-09 | 2016-05-31 | Teijin Pharma Ltd | comprimido que se desintegra intraoralmente |
CN103298466B (zh) | 2010-09-10 | 2015-11-25 | 武田制药美国有限公司 | 茶碱和非布索坦的联合治疗方法 |
EP2502920A1 (en) | 2011-03-25 | 2012-09-26 | Sandoz Ag | Crystallization process of Febuxostat from A |
WO2012153313A1 (en) | 2011-05-11 | 2012-11-15 | Ranbaxy Laboratories Limited | Pharmaceutical composition of febuxostat |
US20140112992A1 (en) * | 2011-06-06 | 2014-04-24 | Hetero Research Foundation | Process for febuxostat |
WO2013001441A1 (en) * | 2011-06-29 | 2013-01-03 | Ranbaxy Laboratories Limited | Dry formulations of febuxostat |
WO2013088449A1 (en) | 2011-12-16 | 2013-06-20 | Natco Pharma Limited | Stable crystal form of febuxostat and process for the preparation thereof |
EP2925306A1 (en) | 2012-07-12 | 2015-10-07 | Alembic Pharmaceuticals Limited | Pharmaceutical composition of febuxostat |
EP2692342A1 (en) * | 2012-07-30 | 2014-02-05 | Interquim, S.A. | Process for the preparation of pharmaceutical compositions comprising febuxostat in the form of tablets |
US20140051733A1 (en) * | 2012-08-14 | 2014-02-20 | Dr. Reddy's Laboratories Ltd. | Febuxostat pharmaceutical compositions |
WO2014057461A1 (en) | 2012-10-11 | 2014-04-17 | Ranbaxy Laboratories Limited | Process for the preparation of crystalline form g of febuxostat |
WO2014125504A2 (en) * | 2013-02-18 | 2014-08-21 | Hetero Research Foundation | Pharmaceutical compositions of febuxostat |
SG11201509738RA (en) | 2013-05-31 | 2015-12-30 | Takeda Pharmaceuticals Usa Inc | Methods of treatment and compositions with xanthine oxidase inhibitors |
CN103588723B (zh) * | 2013-09-10 | 2015-05-20 | 杭州华东医药集团新药研究院有限公司 | 一种非布司他晶型a的制备方法 |
CN103588724B (zh) * | 2013-09-10 | 2015-05-20 | 杭州华东医药集团新药研究院有限公司 | 一种非布司他晶型a及其制备方法 |
WO2015063561A1 (ja) * | 2013-10-22 | 2015-05-07 | 日本ケミファ株式会社 | 2—[3—シアノ—4—(2—メチルプロポキシ)フェニル]—4—メチルチアゾ一ル—5—力ルボン酸の小型化結晶、その微粉化物及びこれらを含有する固形製剤 |
EP2881116A1 (en) | 2013-12-05 | 2015-06-10 | Ranbaxy Laboratories Limited | Febuxostat composition |
EP2902016A1 (en) | 2014-01-30 | 2015-08-05 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Febuxostat tablet |
CZ27857U1 (cs) | 2014-12-12 | 2015-02-23 | Zentiva, K.S. | Formulace obsahující tuhý roztok febuxostatu |
WO2016171254A1 (ja) * | 2015-04-22 | 2016-10-27 | 日本ケミファ株式会社 | 2-[3-シアノ-4-(2-メチルプロポキシ)フェニル]-4-メチルチアゾール-5-カルボン酸の結晶、その製造方法、及びそれらの利用 |
GR1009119B (el) * | 2016-06-30 | 2017-09-18 | "Φαρματεν Α.Β.Ε.Ε." | Φαρμακευτικο σκευασμα περιεχον ενα μη πουρινικο επιλεκτικο αναστολεα της οξειδασης της ξανθινης και μεθοδος παρασκευης αυτου |
CN106511288A (zh) * | 2016-12-20 | 2017-03-22 | 天津泰普制药有限公司 | 一种非布司他片剂的制备方法 |
WO2018199928A1 (en) | 2017-04-25 | 2018-11-01 | Hewlett-Packard Development Company, L.P. | Fluid impeller controller |
JP2019142814A (ja) * | 2018-02-21 | 2019-08-29 | 大原薬品工業株式会社 | フェブキソスタット含有錠剤の製造方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0513379T3 (da) | 1990-11-30 | 1996-09-30 | Teijin Ltd | 2-Arylthiazolderivater og farmaceutisk præparat indeholdende sådanne |
AU703609B2 (en) | 1995-04-07 | 1999-03-25 | Teijin Limited | Protective agent for organ or tissue |
CN1210521A (zh) * | 1996-02-02 | 1999-03-10 | 日本新药株式会社 | 异喹啉衍生物及医药 |
PT1956014T (pt) * | 1998-06-19 | 2019-04-24 | Teijin Pharma Ltd | Polimorfos de ácido 2-(3-ciano-4-isobutiloxifenil)-4-metil- 5-tiazolecarboxílico e método para a sua produção |
SE9802973D0 (sv) * | 1998-09-03 | 1998-09-03 | Astra Ab | Immediate release tablet |
-
2003
- 2003-03-28 SI SI200332376T patent/SI1488790T1/sl unknown
- 2003-03-28 AU AU2003220909A patent/AU2003220909B2/en active Active
- 2003-03-28 JP JP2003579817A patent/JP4084309B2/ja not_active Expired - Lifetime
- 2003-03-28 US US10/503,391 patent/US7361676B2/en not_active Expired - Lifetime
- 2003-03-28 CN CNA038069199A patent/CN1642546A/zh active Pending
- 2003-03-28 WO PCT/JP2003/003962 patent/WO2003082279A1/ja active Application Filing
- 2003-03-28 CN CN2010101134147A patent/CN101836978B/zh not_active Ceased
- 2003-03-28 KR KR1020047014130A patent/KR100981905B1/ko active IP Right Grant
- 2003-03-28 PT PT37155868T patent/PT1488790E/pt unknown
- 2003-03-28 EP EP03715586.8A patent/EP1488790B1/en not_active Expired - Lifetime
- 2003-03-28 DK DK03715586.8T patent/DK1488790T3/da active
- 2003-03-28 CA CA2474674A patent/CA2474674C/en not_active Expired - Lifetime
- 2003-03-28 ES ES03715586.8T patent/ES2505690T3/es not_active Expired - Lifetime
-
2014
- 2014-08-20 CY CY20141100662T patent/CY1115490T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
US7361676B2 (en) | 2008-04-22 |
AU2003220909B2 (en) | 2008-09-18 |
EP1488790A1 (en) | 2004-12-22 |
JP4084309B2 (ja) | 2008-04-30 |
CY1115490T1 (el) | 2017-01-04 |
WO2003082279A1 (fr) | 2003-10-09 |
AU2003220909A1 (en) | 2003-10-13 |
CN101836978B (zh) | 2013-09-11 |
JPWO2003082279A1 (ja) | 2005-07-28 |
CN1642546A (zh) | 2005-07-20 |
EP1488790A4 (en) | 2007-06-20 |
CN101836978A (zh) | 2010-09-22 |
CA2474674A1 (en) | 2003-10-09 |
US20050043375A1 (en) | 2005-02-24 |
ES2505690T3 (es) | 2014-10-10 |
EP1488790B1 (en) | 2014-07-16 |
CA2474674C (en) | 2011-04-19 |
PT1488790E (pt) | 2014-10-10 |
KR100981905B1 (ko) | 2010-09-13 |
SI1488790T1 (sl) | 2014-09-30 |
KR20040101284A (ko) | 2004-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1488790T3 (da) | Fast præparat indeholdende en enkeltkrystalform A af etthiazolcarboxylsyrederivat | |
NO20220690A1 (no) | Stabil krystall av 4-oxoquinolinforbindelse | |
CY2016042I2 (el) | Νεες ετεροκυκλικες ενωσεις δραστικες ως αναστολεις των βητα-λακταμασων | |
DK4008721T3 (da) | Syntese af boronester og syre forbindelser | |
DK1680137T3 (da) | Makrocyklisk carboxylsyre- og acylsulfonamidforbindelse som inhibitor af HCV-replikation | |
LU92025I2 (fr) | Méthanesulfonate d'éthylester d'acide 3-¬(2-{¬4-(hexyloxy-carbonylamino-imino-méthyl)-phénylamino-méthyl}-1-méthyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino-propionique | |
DK1660431T3 (da) | Phenoxyeddikesyrederivater | |
IS8231A (is) | Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða | |
DK1522539T3 (da) | Krystallinsk komposition indeholdende excitalopram | |
DK1487832T3 (da) | Krystallinsk mikronisat af tiotropiumbromid | |
ATE403375T1 (de) | Pestizide zusammensetzung enthaltend einen laktat ester als kristallwachstumshemmer | |
ATE364610T1 (de) | Kristalline polymorphe form von irinotecan- hyrochlorid | |
IS8232A (is) | Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða | |
DK1567482T3 (da) | Fremgangsmåde til fremstilling af phenylmalonsyre-dinitriler | |
IL162167A0 (en) | Metabolites of (3-äÄ4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-aminoÜ-methylü-phenoxy)-acetic acid | |
DE50313212D1 (de) | Blausäure aus formamid | |
DK1519928T3 (da) | Fremgangsmåde til fremstilling af heterocykliske fluoralkenylsulfoner | |
IS6633A (is) | Samsetningar af fínasteríð töflum | |
DK1403264T3 (da) | Fremgangsmåde til industriel syntese af methyldiesteren af 5-amino-3-carboxylmethyl-4-cyano-2-thiophencarboxylsyre | |
DK1513806T3 (da) | Sulfonsyresalte af sulfonsyrederivater | |
DE602004016734D1 (de) | Flüssigkristalline zusammensetzung | |
DK1511741T3 (da) | Esterderivater af en decahydroisoquinolin-3-carboxylsyre som analgetika | |
DK1554303T3 (da) | Polymorf B af en kendt thiophencarboxylsyredodecahydrocyclopenta[a]phenanthrenylester | |
DK1497290T3 (da) | Fremgangsmåde til fremstilling af syresalte af gemifloxacin | |
ITPA20030031A1 (it) | Composizioni che contengono acido l-ascorbico stabilizzato |